Perelman School of Medicine

A new alteration to the way T cells are engineered has significant implications for using engineered T cells to fight both HIV and cancer.

The Presidential Assistant Professor in microbiology runs the Jurado lab, which studies emerging virus pathogenesis and immunology, while leading and supporting equity and justice initiatives.

Student interns worked this summer with the Davis Lab in the Penn Epilepsy Center to research improvements to epilepsy diagnosis using the tools of machine learning and network analysis.

A buildup of tau protein in parts of the brain helped Edward Lee, an assistant professor of pathology and laboratory medicine, and other Penn scientists uncover this new form of dementia.

A Penn clinical trial shows health care workers in contact with COVID-19 patients who took hydroxychloroquine daily did not reduce their rate of infection.

Amid nationwide demonstrations calling for the long-overdue dismantling of racist systems and institutions, the vice dean for Inclusion and Diversity and professor of ophthalmolog has been busy sharing her voice and taking action.

Single cell sequencing aided researchers in identifying a previously undiscovered molecule in the brain.

The identification of this epigenetic process highlights potential drug treatment strategies for early-stage disease treatment.

A Penn Medicine study finds commercials from pharmaceutical companies advertising medication to treat psoriasis and eczema lack people from racial and ethnic minorities.

As a high school student, junior Darcey Hookway spent time volunteering on a dementia ward at a local hospital. “The social aspect of their condition really struck me,” says Hookway, who is from London. “They struggled immensely with social isolation. And now with COVID exacerbating that more than ever, I think that’s a huge detriment to their health.”